GLP-1 receptor agonist drugs appear to have bone-protective effects potentially through preservation of lean muscle mass during weight loss.
Tag: Bone
Semaglutide Linked to 15% Decrease in Bone Fractures Compared to Other Weight-Loss Drugs
New research shows semaglutide not only leads to greater weight loss but also significantly reduces the risk of bone fractures in treated patients.